Why Am I So Tired All the Time?

Fatigue Is a Symptom, Not a Diagnosis

Feeling tired is your body's signal that something physiological or psychological is out of balance. Fatigue that persists beyond two to three weeks, does not improve with a full night of sleep, or limits your ability to work or care for yourself deserves a clinical evaluation rather than another cup of coffee.

The CDC defines insufficient sleep as fewer than 7 hours per night for adults, and its 2020 data show that 35.2% of U.S. Adults report falling below that threshold routinely [1]. Sleep quantity alone, however, does not explain all fatigue. Sleep quality, hormonal status, nutritional sufficiency, and metabolic health all play independent roles.

Acute Versus Chronic Fatigue

Acute fatigue lasts days to weeks and typically traces to an identifiable trigger: a viral illness, travel across time zones, an unusually demanding work period, or bereavement. Chronic fatigue persists for six or more months and often lacks an obvious single cause.

The diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) requires at least six months of profound fatigue that is not improved by rest, plus post-exertional malaise and either cognitive impairment or unrefreshing sleep. The National Academy of Medicine estimates ME/CFS affects between 836,000 and 2.5 million Americans, yet more than 80% remain undiagnosed [2].

Why Women Are Disproportionately Affected

Women report fatigue at higher rates than men across nearly every age group. The gap widens significantly in the 40-55 age band, which corresponds with perimenopause. Estrogen and progesterone both modulate sleep architecture, thermoregulation, and serotonin metabolism. As those hormones fluctuate, sleep fragmentation increases and daytime energy declines.

Thyroid Dysfunction: The Most Commonly Missed Cause

Hypothyroidism is the single most frequently overlooked medical cause of chronic fatigue in primary care settings. The thyroid gland regulates basal metabolic rate; when thyroid hormone output falls, every cell in the body runs slower.

The American Thyroid Association estimates that 20 million Americans have some form of thyroid disease, and up to 60% are unaware of their condition [3]. Subclinical hypothyroidism, defined as a TSH above the laboratory reference range with normal free T4, produces fatigue, brain fog, and cold intolerance even before overt disease develops.

TSH Target Ranges and Treatment

Standard treatment uses levothyroxine (L-T4), with a target TSH of 0.5-2.5 mIU/L in most adults according to the American Association of Clinical Endocrinology [4]. Some patients on L-T4 monotherapy continue to report fatigue; a 2019 meta-analysis in the Journal of Clinical Endocrinology and Metabolism found that combination T4/T3 therapy improved quality-of-life scores in a subset of hypothyroid patients who carry the DIO2 gene variant [5].

Hashimoto's Thyroiditis

Hashimoto's thyroiditis, the autoimmune form of hypothyroidism, may produce fatigue even when TSH is technically "normal." Elevated thyroid peroxidase antibodies (TPO-Ab) signal ongoing immune activity that can cause symptoms. Testing TPO-Ab alongside TSH gives a more complete picture.

Iron-Deficiency Anemia: A Global Cause of Exhaustion

Iron deficiency is the world's most widespread nutritional deficiency. The WHO estimates it affects approximately 1.62 billion people, roughly 24.8% of the global population [6]. In the United States, premenopausal women are at highest risk due to monthly menstrual blood loss.

Ferritin, the storage form of iron, is the most sensitive marker. A ferritin below 30 ng/mL can produce fatigue even when hemoglobin remains within the normal reference range. The 2023 American Society of Hematology guidelines recommend treating symptomatic iron deficiency with oral ferrous sulfate 325 mg (65 mg elemental iron) once to three times daily, with repeat ferritin testing at 8-12 weeks [7].

Oral vs. Intravenous Iron

Oral supplementation corrects most cases within 8-12 weeks. Patients with gastrointestinal intolerance, inflammatory bowel disease, or who do not respond to oral therapy may require intravenous iron. Ferric carboxymaltose (Injectafer) and ferumoxytol (Feraheme) are FDA-approved IV options that can replete iron stores in one to two infusions [8].

B12 and Folate Deficiency

Vitamin B12 deficiency produces a megaloblastic anemia clinically indistinguishable from iron deficiency by symptom alone. Vegetarians, vegans, and adults over 60 are at elevated risk because B12 absorption from food requires adequate gastric acid and intrinsic factor, both of which decline with age. Serum B12 below 200 pg/mL is diagnostic; levels between 200-300 pg/mL are borderline and warrant a methylmalonic acid level to confirm sufficiency [9].

Sleep Disorders: When the Problem Is Not How Long You Sleep

Obstructive sleep apnea (OSA) fragments sleep hundreds of times per night without the patient ever fully awakening. The American Academy of Sleep Medicine estimates OSA affects at least 30 million U.S. Adults, but only 6 million have a formal diagnosis [10]. The hallmark symptom is daytime somnolence despite adequate time in bed.

The Epworth Sleepiness Scale score of 10 or higher suggests clinically significant daytime sleepiness and warrants a sleep study. Home sleep apnea testing (HSAT) is now covered by most insurers and provides an apnea-hypopnea index (AHI) without an overnight laboratory stay.

CPAP Efficacy Data

Continuous positive airway pressure (CPAP) remains the first-line treatment for moderate to severe OSA (AHI >15 events/hour). A Cochrane systematic review of 36 randomized controlled trials found that CPAP significantly reduced Epworth scores (mean difference -2.5 points) and improved driving performance compared with control [11]. Adherence is the limiting factor; heated humidification and auto-titrating CPAP improve mask tolerance and use time.

Restless Legs Syndrome and Periodic Limb Movements

Restless legs syndrome (RLS) affects 5-10% of adults and disrupts sleep onset. Low ferritin is a recognized secondary cause of RLS; the Johns Hopkins Center for Restless Legs Syndrome recommends maintaining ferritin above 75 ng/mL in affected patients, substantially higher than standard anemia cutoffs [12]. First-line pharmacotherapy includes low-dose pramipexole (0.125-0.5 mg at bedtime) or the alpha-2-delta ligands gabapentin enacarbil (Horizant) and pregabalin.

Hormonal Causes: Perimenopause, HRT, and the Fatigue Connection

Perimenopause typically begins 4-8 years before the final menstrual period and produces estrogen and progesterone fluctuations that directly impair sleep. A 2021 study in Menopause (N=3,302) found that women in late perimenopause were 1.98 times more likely to report clinically significant fatigue compared with premenopausal women (P<0.001) [13].

How Estrogen Loss Disrupts Sleep

Estrogen receptors are expressed in the hypothalamic sleep-wake centers. Declining estrogen raises core body temperature set points and increases the frequency of nocturnal awakenings. Each vasomotor episode (hot flash) that occurs during sleep fragments Stage N3 slow-wave sleep, the most restorative phase.

Hormone Replacement Therapy and Fatigue

The Menopause Society (formerly NAMS) 2022 position statement states: "For most healthy women aged younger than 60 years or within 10 years of menopause onset, the benefit-risk ratio is favorable for hormone therapy use" for symptoms including sleep disturbance and fatigue [14]. Estradiol patches (0.05-0.1 mg/day) combined with micronized progesterone (Prometrium) 200 mg at bedtime have shown specific sleep-architecture benefits in randomized trials, reducing nighttime wakefulness by approximately 19% compared with placebo in the KEEPS trial.

Testosterone in Women

Low testosterone in women is a less-discussed but clinically real contributor to fatigue, particularly after surgical menopause or in women on oral estrogen (which raises sex-hormone-binding globulin and lowers free testosterone). The International Society for the Study of Women's Sexual Health 2019 consensus recommends transdermal testosterone at a dose producing a free testosterone level in the normal premenopausal range for women with low sexual desire and fatigue refractory to estrogen therapy alone [15].

Mental Health Conditions and Fatigue

Depression and anxiety are among the most common causes of persistent fatigue worldwide. The WHO estimates major depressive disorder affects 280 million people globally [16]. Fatigue is a diagnostic criterion for MDD under DSM-5, and an estimated 90% of depressed patients report it as a symptom.

Bidirectional Relationship

Poor sleep worsens mood; low mood worsens sleep. Breaking this cycle requires addressing both simultaneously. Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment recommended by the American College of Physicians and produces durable improvements in sleep onset latency and sleep efficiency that pharmacotherapy alone does not [17].

Pharmacological Options

SSRIs such as escitalopram (Lexapro) and sertraline (Zoloft) reduce depressive fatigue but may initially disrupt sleep architecture by suppressing REM sleep. Bupropion (Wellbutrin), a dopamine and norepinephrine reuptake inhibitor, is an alternative that tends to be activating rather than sedating and does not suppress REM. Mirtazapine 15 mg at bedtime targets histamine H1 receptors and improves sleep continuity while treating depression.

Metabolic Causes: Blood Sugar, Obesity, and GLP-1 Medications

Prediabetes and Type 2 Diabetes

Elevated blood glucose impairs mitochondrial function and promotes systemic inflammation, both of which cause fatigue. The CDC estimates 96 million U.S. Adults have prediabetes, and 80% do not know it [18]. A fasting glucose of 100-125 mg/dL or an HbA1c of 5.7-6.4% qualifies as prediabetes. Intensive lifestyle modification, as tested in the Diabetes Prevention Program (N=3,234), reduced progression to type 2 diabetes by 58% over 2.8 years and improved self-reported energy levels [19].

Obesity and Sleep Architecture

A body mass index (BMI) above 30 increases OSA risk by a factor of roughly 4 and independently reduces slow-wave sleep. Weight loss of 10% produces a mean AHI reduction of approximately 26% according to a meta-analysis published in JAMA Internal Medicine [20].

GLP-1 Receptor Agonists

Semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound) produce substantial weight loss that secondarily improves sleep quality and reduces OSA severity. In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks versus 2.4% with placebo [21]. The SURMOUNT-OSA trial (2024) found tirzepatide 10-15 mg reduced AHI by approximately 55-63% over 52 weeks in adults with OSA and obesity [22]. Patients who experience fatigue during the titration phase of GLP-1 therapy should increase fluid intake and ensure adequate protein (at minimum 1.2 g/kg body weight/day), as caloric restriction can temporarily worsen energy levels.

Nutritional Deficiencies Beyond Iron

Vitamin D

Vitamin D receptors are present in nearly every tissue, including skeletal muscle. A serum 25-hydroxyvitamin D below 20 ng/mL is classified as deficient by the Endocrine Society; levels below 30 ng/mL are considered insufficient [23]. A 2020 systematic review in Nutrients (17 RCTs) found that vitamin D supplementation significantly improved fatigue severity scores compared with placebo, with the largest effects seen in patients with baseline levels below 25 ng/mL [24].

Magnesium

Magnesium acts as a cofactor in over 300 enzymatic reactions, including ATP synthesis. The National Institutes of Health estimates that 48% of Americans consume less than the recommended dietary allowance (RDA) of magnesium [25]. Magnesium glycinate or malate at 200-400 mg at bedtime may improve sleep efficiency and reduce fatigue in deficient individuals, though evidence from large RCTs remains limited.

Medications That Cause Fatigue

Several commonly prescribed drugs produce sedation or mitochondrial impairment as a side effect. Beta-blockers such as metoprolol and atenolol reduce cardiac output and may lower exercise tolerance. Statins affect coenzyme Q10 synthesis in a subset of patients and can cause myopathy with associated fatigue. Antihistamines (diphenhydramine in OTC sleep aids), benzodiazepines, and certain antihypertensives all contribute. A medication reconciliation review with a pharmacist or physician is warranted before attributing fatigue to an idiopathic cause.

A Practical Diagnostic Approach

The initial workup for unexplained fatigue lasting more than two weeks should include: complete blood count (CBC), comprehensive metabolic panel (CMP), TSH with reflex free T4, ferritin, serum iron and total iron-binding capacity, 25-hydroxyvitamin D, HbA1c, and a depression screening tool such as the PHQ-9.

Second-tier testing, based on clinical suspicion, adds: cortisol (morning, 8 AM), free and total testosterone, estradiol and FSH (in women aged 35-55), TPO antibodies, serum B12, and an overnight sleep study.

A PHQ-9 score of 10 or higher suggests moderate depression and warrants a treatment conversation before attributing fatigue to a purely physical cause. Many patients have overlapping causes, for example, subclinical hypothyroidism plus iron deficiency plus perimenopausal sleep disruption, that compound each other.

When to Seek Urgent Evaluation

Fatigue accompanied by chest pain, shortness of breath at rest, syncope, unexplained weight loss exceeding 5% of body weight in one month, night sweats, or lymphadenopathy requires same-day or emergency evaluation to rule out cardiac, pulmonary, or malignant causes.